Condition
Residual Kidney Function clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Residual Kidney Function clinical trials that are recruiting, at sites in 2 countries (most in Hong Kong (1), Canada (1)). By phase: Phase 2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Using empagliflozin to improve kidney function in new peritoneal dialysis patients
This study tests if adding a diabetes medication called empagliflozin can help new peritoneal dialysis patients keep their kidney function and improve their overall health.
-
Investigating the safety and mechanisms of SGLT2 inhibitors in patients on peritoneal dialysis
This study is testing if a diabetes medication called empagliflozin is safe and helpful for people on peritoneal dialysis who still have some kidney function, to see if it can protect their heart and kidneys.
Related topics
Quick answers
How many Residual Kidney Function clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Hong Kong (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.